DK1345658T3 - Fremgangsmåder og vacciner til tilvejebringelse af in ovo-beskyttelse mod kalkun-rhinotracheitis - Google Patents

Fremgangsmåder og vacciner til tilvejebringelse af in ovo-beskyttelse mod kalkun-rhinotracheitis

Info

Publication number
DK1345658T3
DK1345658T3 DK01989322T DK01989322T DK1345658T3 DK 1345658 T3 DK1345658 T3 DK 1345658T3 DK 01989322 T DK01989322 T DK 01989322T DK 01989322 T DK01989322 T DK 01989322T DK 1345658 T3 DK1345658 T3 DK 1345658T3
Authority
DK
Denmark
Prior art keywords
vaccines
methods
providing
protection against
turkey rhinotracheitis
Prior art date
Application number
DK01989322T
Other languages
Danish (da)
English (en)
Inventor
Frans Gerrit Davelaar
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22954857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1345658(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1345658T3 publication Critical patent/DK1345658T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01989322T 2000-11-21 2001-11-13 Fremgangsmåder og vacciner til tilvejebringelse af in ovo-beskyttelse mod kalkun-rhinotracheitis DK1345658T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25216200P 2000-11-21 2000-11-21
PCT/US2001/051207 WO2002045745A2 (en) 2000-11-21 2001-11-13 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis

Publications (1)

Publication Number Publication Date
DK1345658T3 true DK1345658T3 (da) 2007-09-17

Family

ID=22954857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01989322T DK1345658T3 (da) 2000-11-21 2001-11-13 Fremgangsmåder og vacciner til tilvejebringelse af in ovo-beskyttelse mod kalkun-rhinotracheitis

Country Status (25)

Country Link
US (2) US20030054016A1 (bg)
EP (1) EP1345658B1 (bg)
JP (1) JP2004536780A (bg)
KR (1) KR20030055314A (bg)
CN (1) CN100379452C (bg)
AR (1) AR031405A1 (bg)
AT (1) ATE361120T1 (bg)
AU (2) AU4342602A (bg)
BG (1) BG107826A (bg)
BR (1) BR0115507A (bg)
CY (1) CY1106707T1 (bg)
CZ (1) CZ20031419A3 (bg)
DE (1) DE60128264T2 (bg)
DK (1) DK1345658T3 (bg)
ES (1) ES2284717T3 (bg)
HK (1) HK1055914A1 (bg)
HR (1) HRP20030508A2 (bg)
HU (1) HUP0302343A2 (bg)
MX (1) MXPA03004432A (bg)
NZ (1) NZ526556A (bg)
PL (1) PL365848A1 (bg)
PT (1) PT1345658E (bg)
WO (1) WO2002045745A2 (bg)
YU (1) YU38503A (bg)
ZA (1) ZA200304762B (bg)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115287270B (zh) * 2022-10-09 2023-01-06 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） B亚型禽偏肺病毒传代致弱株及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
CA2156423A1 (en) * 1993-02-26 1994-09-01 Mark D. Cochran Recombinant fowlpox viruses and uses thereof
US6221361B1 (en) * 1995-01-19 2001-04-24 Syntro Corporation Recombinant swinepox virus
FR2750866B1 (fr) * 1996-06-27 1998-11-27 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2751225B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
EP0848956A1 (en) 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo vaccination against Newcastle Disease
FR2758986B1 (fr) * 1997-01-31 1999-04-30 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
AU2001237016A1 (en) 2000-02-29 2001-09-12 Wyeth In ovo protection against infectious bronchitis

Also Published As

Publication number Publication date
HK1055914A1 (en) 2004-01-30
US7348012B2 (en) 2008-03-25
MXPA03004432A (es) 2003-08-19
KR20030055314A (ko) 2003-07-02
PT1345658E (pt) 2007-08-09
NZ526556A (en) 2006-06-30
DE60128264T2 (de) 2008-01-10
AU2002243426B2 (en) 2007-05-17
PL365848A1 (en) 2005-01-10
CZ20031419A3 (cs) 2004-02-18
ATE361120T1 (de) 2007-05-15
WO2002045745A2 (en) 2002-06-13
CN1486206A (zh) 2004-03-31
CN100379452C (zh) 2008-04-09
ZA200304762B (en) 2005-03-30
US20060034868A1 (en) 2006-02-16
US20030054016A1 (en) 2003-03-20
ES2284717T3 (es) 2007-11-16
EP1345658B1 (en) 2007-05-02
HRP20030508A2 (en) 2004-08-31
AR031405A1 (es) 2003-09-24
BG107826A (bg) 2004-02-27
CY1106707T1 (el) 2012-05-23
JP2004536780A (ja) 2004-12-09
HUP0302343A2 (hu) 2003-10-28
YU38503A (sh) 2006-05-25
AU4342602A (en) 2002-06-18
WO2002045745A3 (en) 2002-11-28
EP1345658A2 (en) 2003-09-24
DE60128264D1 (de) 2007-06-14
BR0115507A (pt) 2005-09-20

Similar Documents

Publication Publication Date Title
FI20000819A (fi) Menetelmä vastaanottimessa ja vastaanotin
IS2985B (is) Forlyf af fosfónat-kirna hliðstæðum og aðferð til að velja og búa þær til
DK1023904T3 (da) Adjuvanser til anvendelse i vacciner
DE60125437D1 (de) Mehrwegedetektor und zugehöriges Verfahren
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK2474694T3 (da) Sikkerhedsindretning og frigivelsesindretning
DK1339292T3 (da) Sammensætning og fremgangsmåde
FIU20010184U0 (fi) Sisäänvientikiristin ja johtosuoja
DK2262280T3 (da) Fremgangsmåde og system til beskyttelse mod akustisk chok
NO20032303D0 (no) Frysetörket pantoprazol-preparat og pantoprazol-injeksjon
DK1265482T3 (da) Vandige formulationer og fremgangsmåde til fremstilling af samme
DE60127165D1 (de) Unterschrift-Kodierungsverfahren
DK1311731T3 (da) Fremgangsmåde og arrangement til stolpesystem
DE60010423D1 (de) Geheimübertragungsverfahren und -Vorrichtung
FI20000715A0 (fi) Ryhmätyömenetelmä ja -järjestelmä
DE60044426D1 (de) Weiterleitungsvorrichtung und -Verfahren
GB0104152D0 (en) Apparatus for flood protection in houses
NO20026164D0 (no) Benzoksazepinoner og deres anvendelse som squalen syntase inhibitorer
DK1259257T3 (da) In-ovo beskyttelse mod infektiøs bronchitis
DK1345658T3 (da) Fremgangsmåder og vacciner til tilvejebringelse af in ovo-beskyttelse mod kalkun-rhinotracheitis
DK1131414T3 (da) Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf
NO20024105L (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
DK1073462T3 (da) Kombinationsvaccine mod hepatitis A og hepatitis B
ITMI20000340A0 (it) Metodo e dispositivo per saldatura